From Reuters.

Novo Nordisk’s top investor moved to take control of the drugmaker’s board, vowing a sharper focus on the key US market to revive sales of blockbuster weight-loss drug Wegovy as Novo’s chair and six independent board members quit.

#News #Reuters #Newsfeed #novonordisk #wegovy #wegovyweightloss #weightlossdrugs

Read the story here: https://reut.rs/3L6v15w

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en